Rhodes Jennifer J
EVP, CHIEF LEGAL OFFICER, SEC
Rhodes Jennifer J has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Mar 26, 2026.
On the most recent filing, Rhodes Jennifer J is listed as EVP, CHIEF LEGAL OFFICER, SEC at ACADIA PHARMACEUTICALS INC. Inside the rolling window, Rhodes Jennifer J reported no open-market purchases and 2 open-market sales totaling $245K in ACAD. The largest disclosed transaction in the window is a sale of 6,950 ACAD shares on Feb 9, 2026, worth $162K.
Companies traded
Other insiders at ACAD
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$245K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Rhodes Jennifer J made?
Rhodes Jennifer J has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company since 2026.
Which companies does Rhodes Jennifer J trade?
Rhodes Jennifer J has filed SEC Form 4 disclosures for 1 company, including ACAD.
When was Rhodes Jennifer J's most recent SEC Form 4 filing?
Rhodes Jennifer J's most recent SEC Form 4 filing on Tracefour is dated Mar 26, 2026.
What is Rhodes Jennifer J's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Rhodes Jennifer J is listed as EVP, CHIEF LEGAL OFFICER, SEC.
What is Rhodes Jennifer J's total buy and sell value in the current window?
Inside the rolling retention window, Rhodes Jennifer J bought $0 and sold $245K based on SEC Form 4 filings.
What was Rhodes Jennifer J's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 6,950 ACAD shares on 2026-02-09, worth $162K, per SEC Form 4 filings.